🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical trial is to learn about the interaction of sis...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2018-11-07
Trial ID
NCT03782662
Treatments Being Tested
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested
A Pivotal Phase 1, Randomized, Single-Dose, 4-Period, Crossover Relative Bi...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2020-12-01
Trial ID
NCT04767035
Treatments Being Tested
To assess the influence of BI 187004 on kinetics of cytochrome P450 (CYP) a...
Status
Completed
Location
1307.19.1 Boehringer Ingelheim Investigational Site
Start Date
2014-10
Trial ID
NCT02254148
Treatments Being Tested
Evaluate the safety and tolerability of sotorasib in adult subjects with KR...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2018-08-27
Trial ID
NCT03600883
Treatments Being Tested
This study is a single-center, open label phase I clinical study to charact...
Status
Completed
Location
the Second Affiliated Hospital of Guangzhou Medical University
Start Date
2023-06-25
Trial ID
NCT05942365
Treatments Being Tested
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested
This study is designed to assess 1) the effect of multiple doses of itracon...
Status
Completed
Location
Celerion
Start Date
2019-10-18
Trial ID
NCT04142762
Comparative Bioavailability study testing MELT-100 (midazolam and ketamine ...
Status
Completed
Location
WWCT
Start Date
2020-07-20
Trial ID
NCT04485702
Treatments Being Tested
Phase 1, open-label, non-randomized, three-treatment, one-sequence interact...
Status
Completed
Location
Research Site
Start Date
2025-05-14
Trial ID
NCT06979973
Treatments Being Tested